| Budget Amount *help |
¥24,050,000 (Direct Cost: ¥18,500,000、Indirect Cost: ¥5,550,000)
Fiscal Year 2020: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2019: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2018: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2017: ¥6,890,000 (Direct Cost: ¥5,300,000、Indirect Cost: ¥1,590,000)
|
|---|
| Outline of Final Research Achievements |
"Drug resistance" is a major problem that hinders the remission of cancer, and it is necessary to develop a therapeutic method that overcomes drug resistance. So far, the principal investigator has identified a protein that is highly expressed in many types of cancer, and promotes the survival and drug resistance of various cancers. In this research project, we screened for small molecule compounds and found multiple compounds that inhibit the function of this factor. We also identified several proteins that bind to and control this factor.
|
